Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Collection Sites Provides Update With January Sales of 73,973 Tests at an Average Price of $96 .
Medivolve Inc.February 4, 2021 GMT
To date Collection Sites has launched a total of 62 sites across its network with additional new openings in Texas, Florida, and North Carolina. Further, Medivolve will host a webinar today, Thursday, February 4th at 1 pm ET.
TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to provide investors with a sales update and announces the launch of new COVID-19 testing centres by its wholly owned subsidiary, Collection Sites, LLC. Collection Sites has launched new sites in Texas, Florida, and North Carolina.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medivolve Enters Into Agreement to Acquire 100% of Noble Bioscience Corp. and Its Agency Rights .
Medivolve Inc.February 2, 2021 GMT
Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that converts into a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days after only ~30 seconds of contact. Further, Medivolve will host a webinar Thursday, February 4
th
at 1 pm ET.
TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) has entered into an agreement to acquire 100% of Noble Bioscience Corp. (“Noble Bioscience”) in exchange for 12.5 million common shares of Medivolve. Noble Bioscience holds the agency rights to Nuturell’s Surface Shield technology in the United States, Canada and Caribbean countries. Medivolve’s subsidiary Collection Sites, LLC will lead
Medivolve Enters Into Agreement to Acquire 100% of Noble Bioscience Corp and Its Agency Rights to Nuturell s COVID-19 Surface Shield Technology yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Medivolve Inc. Pays Tribute to Strategic Advisor Larry King
TORONTO, Jan. 25, 2021
Medivolve, Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) released a statement on the passing of its strategic advisor, Larry King. With great sadness, we honor the death of our advisor and friend. Larry King was a pioneer in broadcasting, a respected colleague, and a kind-hearted soul who was committed to working towards a better and brighter future.
When our company began, Larry saw potential in our company and promise in our work, which was focused on sustainability and the improvement of our planet. We benefited greatly from his wise counsel. Investors can watch a video interview between Medivolve advisors Dr. King and Richard Dolan on YouTube.
Medivolve Announces Closing of Bought Deal Private Placement
January 26, 2021 09:07 ET | Source: Medivolve Inc. Medivolve Inc. Montreal, Quebec, CANADA
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Jan. 26, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“
Medivolve” or the “
Company”) (NEO:MEDV; FRA:34C1) is pleased to announce that it has closed the previously announced bought deal private placement of an aggregate of 20,000,000 units (the “
Units”) at a price per Unit of $0.25 (the “
Issue Price”) for aggregate gross proceeds to the Company of $5,000,000 (the “
Offering”). Canaccord Genuity Corp. (“
Each Unit consists of one common share of the Company (a